At KinetiCor, our vision is simple to make MR images razor sharp.
Kineticor is a medical imaging company dedicated to bringing clarity to MR imaging. Our goal is to become the market leader in providing the most advance and cost effective Prospective Motion Correction Technologies to the healthcare industry. KinetiCor is working with the world’s top researchers in MR motion correction technology to stay at the leading edge of this field.
KinetiCor’s patented prospective motion correction optical imaging technology delivers unparalleled performance to fully optimized MR imaging. We invite you to explore our website and “Contact Us” to learn more about KinetiCor, our technology, and how we can help you improve your MR images.
Barry M. Weinman – Chairman
Founding partner of Allegis Capital a $700M venture fund in Silicon Valley, Mr. Weinman has over 30 years of venture capital and over 15 years of operations experience. Examples of top companies: Columbia/HCA (NYSE), Extreme Networks (NASDAQ), PALM (NASDAQ), Women.com (NASDAQ), Medscape (NASDAQ).
Dr. Jeffrey Yu – CEO
Physician/Entrepreneur with board certifications in radiology and nuclear medicine and MR research experience at the Lucas Center at Stanford. Dr. Yu has held multiple executive level positions in health care organizations and startups; most recently as CTO of Queen’s Medical Center, and as Founder & CTO of OneMedNet – a medical image transfer software company.
Will H. Alameida – COO
Entrepreneur with 25 years of technology management and commercialization experience, with a focus on information technology, medical imaging and biotechnology. Most recently Mr. Alameida served as Founding CEO of PanThera Biopharma, previous executive and managerial roles at STI Medical Systems, MIPS Computer Systems and Apple Computer.
Thomas Ernst, Ph.D.
Dr. Ernst is a Professor at the John A. Burns School of Medicine, University of Hawaii, where he is Principle Investigator of a National Institute of Health multi-center program focused on Motion Tracking for Real-Time Adaptive MR Imaging. He obtained his Ph.D. in Physics from the University of Freiburg, Germany, and held faculty positions at UCLA and the Brookhaven National Laboratory (BNL). Dr. Ernst is a Deputy Editor for the Journal of Magnetic Resonance in Medicine, and has been a reviewer for multiple Scientific Journals and Societies.
Oliver Speck, Ph.D.
Dr. Speck is Professor for Biophysics and Director of the Department of Biomedical Magnetic Resonance, Otto-von-Guericke University, Magdeburg, Germany. He obtained his Ph.D. in Physics at the University of Freiburg, Germany, where he also served as Research Director for the Dept. of Diagnostic Radiology. Dr. Speck is the Deputy Editor for the Journal of Magnetic Resonance in Medicine.
Thomas Prieto, Ph.D.
Dr. Prieto is Associate Professor of Neurology, Medical College of Wisconsin, U.S. He obtained his Ph.D. in Biomedical Engineering at Marquette University, U.S. He was Technical Director of a human motion analysis laboratory and has had funding to assess the feasibility of a novel ambulatory system for measuring human motion. Dr. Prieto has provided technical support for the functional imaging projects at the Medical College of Wisconsin since 1995.
Maxim Zaitsev, Ph.D.
Dr. Zaitsev is the Principal Investigator at the Department of Radiology, Medical Physics, University Medical Centre Freiburg, Germany, and the Scientific Director of the Magnetic Resonance Development and Application Center (MRDAC). He obtained his Ph.D. in Physics at the University of Cologne, Germany. Dr. Zaitsev is Deputy Editor for Engineering Systems for the Journal of Magnetic Resonance Imaging and serves as Co-Organizer of the “Motion Correction Study Group”, International Society for Magnetic Resonance in Medicine (ISMRM) since 2009.
Maastricht University, The Netherlands
Max Planck Institute, Tuebingen, Germany
Medical College of Wisconsin, U.S.A.
National Institute of Communications and Technology, Japan
National Institute of Health, U.S.A.
Otto-von-Guerricke University of Magdeburg, Germany
San Francisco VA Medical Center, U.S.A.
The Queens Medical Center, U.S.A.
University College of London, England
University of Freiburg, University Medical Center, Germany
University of Hawaii, John A. Burns School of Medicine, U.S.A.
University of Lausanne, LREN, Switzerland
University of Minnesota, Center for Magnetic Resonance Research, U.S.A.
University of Wisconsin at Milwaukee, U.S.A.
Washington University at Saint Louis, U.S.A.
Prospective motion correction systems will have a profound impact on the quality and costs of clinical and research MR imaging. Significant savings will be realized by reducing the need to repeat scans and the need to sedate patients to reduce motion during scanning. This system is an extraordinary integration of real-time control of imaging sequences with a novel method for measuring motion. The system has demonstrated remarkable results that are likely to continue to improve with ongoing development.”
Thomas Prieto, Ph.D., Associate Professor of Neurology, Medical College of Wisconsin
From the very beginning of the project back in 2003 we have believed that the prospective motion correction will revolutionize MRI, especially in non-cooperative subjects and patients. It’s been a long way though, until the tracking technology and the MRI methodology has matured to the present point when we were able to demonstrate its real benefits for the image quality. Interestingly, the prospective motion correction has in a way outperformed our expectations, as it not only effectively suppresses the artifacts for the cases with strong motion, but also improves high-resolution acquisitions when no apparent motion is present.”
Maxim Zaitsev, Ph.D., Department of Radiology, University Medical Centre Freiburg
I consider prospective motion correction technology a major break-through in MRI for clinical and academic applications. In diagnostic imaging it will reduce the number of repeat exams or non-diagnostic results, thus allowing better diagnosis and reducing healthcare costs. In addition, technical advances in MRI lead to ever increasing resolution of MRI images, demanding patients to hold extremely still. The full potential of high resolution imaging will only be unleashed with motion correction technology.”
Oliver Speck, Ph.D., Director, Department of Biomedical Magnetic Resonance, Otto-von-Guericke University
Prospective motion correction will have a huge impact for clinical MRI. It is the patients who need MRI the most who also move the most during the scan – children or the elderly, or patients who have head trauma, dementia, Parkinson’s disease, or brain tumors. With potential cost savings on the order of $1 billion per year, MRI scans may eventually become less expensive and therefore more affordable, which means more people can benefit from an MRI.”
Thomas Ernst, Ph.D., John A. Burns School of Medicine, University of Hawaii